George Ng
Chief Executive Officer at PROCESSA PHARMACEUTICALS, INC.
Net worth: 53 095 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Young | M | 71 | 13 years | |
| Anthony Mack | M | 62 |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA.
IACTA Pharmaceuticals, Inc.
 IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | 8 years |
| Heeh-Young Lee | M | 54 |
Calidi Biotherapeutics, Inc. (United States)
 Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | 8 years |
| Dorman Followwill | M | 60 | 7 years | |
| William Pedranti | M | - |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA.
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | 13 years |
| Wendy Pizarro | F | 53 | - | |
| Alexis Nahama | M | - | 7 years | |
| Yue Wu | M | 62 |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | 8 years |
| James Schoeneck | M | 66 |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | 4 years |
| Patrick Lin | M | 58 | 13 years | |
| Justin Yorke | M | 58 | 7 years | |
| Jaisim Shah | M | 63 |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | 8 years |
| David Lemus | M | 61 | 7 years | |
| Geraldine Pannu | F | 54 | 4 years | |
| Wendy Guy | F | 59 | 13 years | |
| Jim Stanker | M | 67 | 6 years | |
| Damon Burrows | M | - |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | 8 years |
| James Bianco | M | - |
Morphogenesis, Inc.
 Morphogenesis, Inc. BiotechnologyHealth Technology Morphogenesis, Inc. develops targeted immunotherapies research. It focuses on the development of cell and gene therapies for the treatment of cancer. The company was founded by Patricia Lawman and Michael Lawman in 1990 and is headquartered in Tampa, FL. | - |
| Scott Leftwich | M | - | - | |
| Mohammed Khoso Baluch | M | 66 | 2 years | |
| Stephen Thesing | M | - |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | - |
| Allan Camaisa | M | - | - | |
| Henry Ji | M | 59 |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | 8 years |
| Sian Bigora | M | 63 | 13 years | |
| Alan Stewart | M | 60 | 1 years | |
| James Neal | M | 68 | 2 years | |
| Mary Nyberg | F | - | - | |
| Antonio Santidrian | M | 45 | - | |
| Weifei Ye | F | - | - | |
| Kayla Parks | F | - | - | |
| Smythe-Pinkerton Shanique | F | - | - | |
| James Manuso | M | 75 |
Morphogenesis, Inc.
Morphogenesis, Inc. BiotechnologyHealth Technology Morphogenesis, Inc. develops targeted immunotherapies research. It focuses on the development of cell and gene therapies for the treatment of cancer. The company was founded by Patricia Lawman and Michael Lawman in 1990 and is headquartered in Tampa, FL. | - |
| Andrew Jackson | M | 55 | 1 years | |
| Boris Minev | M | 61 | - | |
| Steven Rosenfeld | M | - |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | 3 years |
| Stephen Johnson | M | - |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | - |
| William Farley | M | 68 |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | 8 years |
| Alan List | M | 69 |
Morphogenesis, Inc.
Morphogenesis, Inc. BiotechnologyHealth Technology Morphogenesis, Inc. develops targeted immunotherapies research. It focuses on the development of cell and gene therapies for the treatment of cancer. The company was founded by Patricia Lawman and Michael Lawman in 1990 and is headquartered in Tampa, FL. | - |
| Mark R. Brunswick | M | - | 7 years | |
| Amish A. Patel | M | 47 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ernest de Paolantonio | M | 70 | 6 years | |
| William S. Poole | M | 77 | 9 years | |
| Douglas J. Langston | M | 63 | 3 years | |
| Elly Ryu | F | 43 | 10 years | |
| Mark W. Durand | M | 64 | 1 years | |
| James McNulty | M | 73 | 14 years | |
| Tony Kalajian | M | 54 | - | |
| Dean Ferrigno | M | 60 |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | 1 years |
| Robert Knight | M | 73 | 3 years | |
| George Uy | M | 67 | 7 years | |
| Jerome Zeldis | M | 74 | 3 years | |
| Alfonso Zulueta | M | 61 |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development of a cell delivery system for oncology treatments. The company was founded by Allan Camaisa and is headquartered in San Diego, CA. | - |
| Thomas Vecchiolla | M | 68 | - | |
| David Deming | M | 71 | 3 years | |
| Thomas D'Alonzo | M | 80 | 5 years | |
| Virgil Thompson | M | 84 | 6 years | |
| Douglas O. Ebersole | M | 68 | 2 years | |
| Ricardo J. Gonzalez | M | 53 | 6 years | |
| Barry I. Feinberg | M | 68 | 4 years | |
| Charles Bramlage | M | 63 | 3 years | |
| Amit Bhupendra Shah | M | 57 | 3 years | |
| Kalpana Patel | M | - |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | - |
| Eric Floyd | M | 62 |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | 2 years |
| Jerrold Sendrow | M | 79 |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | 2 years |
| Christine Rosser | F | - |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | - |
| Dilip J. Mehta | M | 91 | 4 years | |
| Deborah Telman | F | 59 | 2 years | |
| Hui Li | M | - | - | |
| Stephen L Klincewicz | M | - | 3 years | |
| David LaPré | M | - | - | |
| Tien-Li Lee | M | 49 |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | 5 years |
| R. Floyd | M | 68 | 3 years | |
| Christopher Nardo | M | 59 | 5 years | |
| Jeffrey Su | M | - | 2 years | |
| Kevin Herde | M | 53 | 1 years | |
| Jessica Wolfe | F | - |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | - |
| Miranda Toledano | F | 47 | 1 years | |
| Amar P. Singh | M | 65 | 1 years | |
| Luigi Lenaz | M | 83 | 8 years | |
| Michael A. Adam | M | 66 | 2 years | |
| Jiong Shao | M | 55 | 2 years | |
| Mitchell P. Cybulski | M | 77 | - | |
| J. Christopher Prue | M | - | - | |
| Andrew Sandler | M | 58 | 2 years | |
| William Stewart | M | - |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | - |
| John Liatos | M | 56 | 1 years | |
| Russell Skibsted | M | 65 | 3 years | |
| Adrian Hepner | M | 62 | 1 years | |
| Abraham Noah Oler | M | 48 | 8 years | |
| Nicholas A. Boyle | M | - | 2 years | |
| David Acheson | M | - | - | |
| Zhenwei Miao | M | 60 | 3 years | |
| Peter Franks | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 93 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- George Ng
- Personal Network
